Baird analyst Brian Skorney reiterated an Outperform rating and $14.00 price target on Applied Therapeutics (NASDAQ: APLT).The analyst commented: "At ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE